Gossamer Bio (GOSS) EBT Margin (2022 - 2025)
Historic EBT Margin for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to 362.73%.
- Gossamer Bio's EBT Margin fell 258600.0% to 362.73% in Q3 2025 from the same period last year, while for Sep 2025 it was 803.97%, marking a year-over-year decrease of 7364000.0%. This contributed to the annual value of 61.34% for FY2024, which is N/A changed from last year.
- Per Gossamer Bio's latest filing, its EBT Margin stood at 362.73% for Q3 2025, which was down 258600.0% from 333.13% recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's EBT Margin ranged from a high of 1698.73% in Q3 2022 and a low of 397.03% during Q1 2025
- Over the past 4 years, Gossamer Bio's median EBT Margin value was 242.37% (recorded in 2024), while the average stood at 634.14%.
- The largest annual percentage gain for Gossamer Bio's EBT Margin in the last 5 years was -258600bps (2025), contrasted with its biggest fall of -3891200bps (2025).
- Quarter analysis of 4 years shows Gossamer Bio's EBT Margin stood at 1655.19% in 2022, then fell by -12bps to 1453.0% in 2023, then tumbled by -83bps to 242.37% in 2024, then tumbled by -250bps to 362.73% in 2025.
- Its EBT Margin stands at 362.73% for Q3 2025, versus 333.13% for Q2 2025 and 397.03% for Q1 2025.